Virtus ETF Advisers’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,686
Closed -$67.8K 626
2024
Q4
$67.8K Sell
1,686
-954
-36% -$43.1K 0.03% 400
2024
Q3
$125K Buy
2,640
+44
+2% +$1.94K 0.06% 346
2024
Q2
$77.5K Sell
2,596
-811
-24% -$28.1K 0.04% 418
2024
Q1
$137K Sell
3,407
-231
-6% -$8.27K 0.07% 337
2023
Q4
$92.6K Sell
3,638
-199
-5% -$3.56K 0.06% 396
2023
Q3
$53.3K Sell
3,837
-378
-9% -$7.6K 0.03% 411
2023
Q2
$96.9K Buy
4,215
+796
+23% +$22.8K 0.06% 398
2023
Q1
$101K Sell
3,419
-1,310
-28% -$42.2K 0.06% 335
2022
Q4
$118K Sell
4,729
-2,493
-35% -$66.5K 0.06% 422
2022
Q3
$157K Buy
7,222
+51
+0.7% +$1.34K 0.06% 346
2022
Q2
$141K Buy
7,171
+4,273
+147% +$99.8K 0.05% 328
2022
Q1
$123K Sell
2,898
-173
-6% -$7.31K 0.06% 260
2021
Q4
$195K Sell
3,071
-1,134
-27% -$66K 0.07% 216
2021
Q3
$247K Sell
4,205
-216
-5% -$12.5K 0.11% 221
2021
Q2
$214K Buy
+4,421
New +$192K 0.09% 294

Other funds holding KYMR